Neera S Narang, MD

Offices

1 location · Permanente Medical Group Inc · 10,928 clinicians in this group

Looking this up.

Plans that list them

4 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Narang’s office at (650) 299-2000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Sort by

Plans whose provider directory lists this clinician

Kaiser Permanente Dual Complete North P2 (HMO D-SNP)	Kaiser Permanente	Listed	Sep 1, 2026
Kaiser Permanente Dual Complete North P23 (HMO D-SNP)	Kaiser Permanente	Listed	Sep 1, 2026
Kaiser Permanente Sr Adv Basic Santa Clara (HMO)	Kaiser Permanente	Listed	Sep 1, 2026
Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO)	Kaiser Permanente	Listed	Sep 1, 2026

California Medical Board record

Licence A118120 · Current

Licensed to practise in California · since 2011 · expires 2027-08-31 · University of California, Irvine College of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Drugs they prescribed that Part D paid

$930,728

Pharmacies billed $930,728 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

1,398 generic and 391 brand-name prescriptions · $930,728 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Xeljanz	79	$204,847	$2,593
Enbrel	28	$136,532	$4,876
Kineret	13	$73,971	$5,690
Orencia	16	$73,612	$4,601
Cosentyx Sensoready (2 Pens)	12	$68,348	$5,696

See all 26 drugs

Sort by

Every Part D drug this clinician prescribed

Xeljanz	79	$204,847	$2,593
Enbrel	28	$136,532	$4,876
Kineret	13	$73,971	$5,690
Orencia	16	$73,612	$4,601
Cosentyx Sensoready (2 Pens)	12	$68,348	$5,696
Otezla	15	$66,308	$4,421
Amjevita(Cf)	35	$56,059	$1,602
Amjevita(Cf)	19	$51,892	$2,731
Rasuvo	26	$28,339	$1,090
Methotrexate	364	$9,124	$25
Hydroxychloroquine Sulfate	210	$7,754	$37
Prednisone	345	$4,013	$12
Leflunomide	91	$3,150	$35
Sulfasalazine	30	$2,503	$83
Mycophenolate Mofetil	13	$2,460	$189
Colchicine	62	$1,983	$32
Cevimeline	15	$1,707	$114
Azathioprine	26	$1,220	$47
Allopurinol	74	$1,048	$14
Leucovorin	70	$981	$14
Pilocarpine	11	$651	$59
Cyclosporine	12	$622	$52
Methylprednisolone	18	$541	$30
Alendronate	47	$461	$10
Famotidine	42	$377	$9
Veo Insulin	30	$213	$7

Year by year

Sort by

Part D prescribing by year

2024	1,821	384	None	21%	$930,728
2023	1,944	381	None	24%	$1,064,245
2022	1,830	328	None	27%	$1,148,296
2021	1,823	338	None	27%	$1,120,760
2020	1,799	362	None	30%	$954,659
2019	1,678	354	None	35%	$1,063,949
2018	669	193	None	None	$452,761
2017	416	116	None	None	$249,115
2016	293	111	8% (24)	26%	$114,001
2015	114	60	13% (15)	21%	$29,470
2014	15	None	0% (0)	None	$729
2013	20	None	None	None	$1,633

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 26 drugs

Sort by

Part D drugs prescribed in 2023

Enbrel	49	$245,401	$5,008
Amjevita(Cf)	44	$125,601	$2,855
Xeljanz	48	$114,500	$2,385
Benlysta	14	$70,615	$5,044
Kineret	12	$67,599	$5,633
Otezla	14	$59,218	$4,230
Orencia	13	$58,369	$4,490
Xeljanz Xr	12	$56,919	$4,743
Actemra	12	$39,738	$3,311
Amjevita(Cf)	12	$28,313	$2,359
Rasuvo	38	$26,698	$703
Methotrexate	404	$9,481	$23
Hydroxychloroquine Sulfate	210	$8,125	$39
Prednisone	384	$5,682	$15
Leflunomide	89	$3,100	$35
Sulfasalazine	36	$2,675	$74
Colchicine	58	$1,469	$25
Azathioprine	26	$1,114	$43
Leucovorin	74	$983	$13
Allopurinol	62	$881	$14
Cyclosporine	12	$679	$57
Pilocarpine	16	$634	$40
Alendronate	51	$524	$10
Diclofenac	15	$388	$26
Veo Insulin	49	$361	$7
Famotidine	33	$304	$9

2022: 25 drugs

Sort by

Part D drugs prescribed in 2022

Enbrel	49	$251,685	$5,136
Humira	46	$204,800	$4,452
Enbrel Sureclick	23	$118,568	$5,155
Xeljanz	43	$118,481	$2,755
Otezla	17	$64,642	$3,802
Humira	13	$57,799	$4,446
Orencia	13	$54,658	$4,204
Xeljanz Xr	12	$53,579	$4,465
Actemra	13	$43,138	$3,318
Actemra Actpen	11	$36,501	$3,318
Hydroxychloroquine Sulfate	194	$12,969	$67
Methotrexate	381	$9,563	$25
Rasuvo	20	$9,296	$465
Prednisone	366	$6,029	$16
Sulfasalazine	53	$3,034	$57
Leflunomide	70	$2,852	$41
Leucovorin	82	$1,690	$21
Colchicine	40	$1,570	$39
Pilocarpine	15	$1,279	$85
Azathioprine	18	$1,160	$64
Allopurinol	44	$927	$21
Alendronate	71	$741	$10
Diclofenac	19	$469	$25
Veo Insulin	50	$364	$7
Famotidine	18	$174	$10

2021: 24 drugs

Sort by

Part D drugs prescribed in 2021

Xeljanz	110	$234,505	$2,132
Humira	41	$211,063	$5,148
Enbrel	33	$162,306	$4,918
Enbrel Sureclick	24	$118,045	$4,919
Xeljanz Xr	18	$77,297	$4,294
Humira	15	$70,209	$4,681
Humira(Cf)	14	$59,483	$4,249
Actemra	15	$48,271	$3,218
Otezla	11	$38,635	$3,512
Hydroxychloroquine Sulfate	207	$10,889	$53
Methotrexate	350	$10,247	$29
Prednisone	333	$9,840	$30
Rasuvo	17	$9,015	$530
Leflunomide	61	$3,578	$59
Azathioprine	28	$2,722	$97
Cevimeline	12	$2,718	$226
Sulfasalazine	50	$2,557	$51
Leucovorin	82	$1,821	$22
Colchicine	27	$1,629	$60
Alendronate	105	$1,097	$10
Allopurinol	42	$1,016	$24
Diclofenac	36	$921	$26
Veo Insulin	47	$300	$6
Meloxicam	13	$88	$7

2020: 24 drugs

Sort by

Part D drugs prescribed in 2020

Xeljanz	133	$268,825	$2,021
Humira	36	$148,907	$4,136
Enbrel	24	$110,496	$4,604
Humira	23	$95,447	$4,150
Xeljanz Xr	21	$84,665	$4,032
Enbrel Sureclick	14	$64,750	$4,625
Cosentyx Pen (2 Pens)	13	$48,033	$3,695
Actemra	13	$35,633	$2,741
Hydroxychloroquine Sulfate	246	$11,633	$47
Colchicine	32	$10,194	$319
Prednisone	321	$9,677	$30
Methotrexate	315	$9,320	$30
Rasuvo	11	$5,529	$503
Pilocarpine	15	$3,838	$256
Leflunomide	53	$3,548	$67
Cevimeline	19	$3,235	$170
Sulfasalazine Dr	21	$2,443	$116
Leucovorin	104	$2,139	$21
Sulfasalazine	26	$1,923	$74
Azathioprine	17	$1,753	$103
Diclofenac	41	$1,735	$42
Alendronate	94	$980	$10
Allopurinol	40	$853	$21
Veo Insulin	49	$126	$3

2019: 26 drugs

Sort by

Part D drugs prescribed in 2019

Xeljanz	118	$218,749	$1,854
Humira	45	$182,767	$4,061
Enbrel	39	$166,517	$4,270
Enbrel Sureclick	24	$103,018	$4,292
Humira	25	$101,199	$4,048
Xeljanz Xr	17	$62,048	$3,650
Cosentyx Pen (2 Pens)	11	$43,012	$3,910
Orencia	11	$40,460	$3,678
Hydroxychloroquine Sulfate	196	$20,545	$105
Colchicine	27	$10,895	$404
Methotrexate	363	$10,763	$30
Prednisone	317	$9,567	$30
Rasuvo	12	$6,049	$504
Leflunomide	37	$5,748	$155
Sulfasalazine Dr	20	$3,411	$171
Pilocarpine	13	$3,247	$250
Cevimeline	15	$3,188	$213
Diclofenac	35	$2,438	$70
Azathioprine	19	$2,215	$117
Allopurinol	45	$1,408	$31
Leucovorin	69	$1,317	$19
Sulfasalazine	19	$1,165	$61
Methylprednisolone	11	$664	$60
Alendronate	36	$390	$11
Famotidine	13	$157	$12
Veo Insulin	35	$102	$3

2018: 10 drugs

Sort by

Part D drugs prescribed in 2018

Xeljanz Xr	33	$111,929	$3,392
Humira	12	$47,108	$3,926
Xeljanz	14	$42,586	$3,042
Colchicine	21	$8,504	$405
Hydroxychloroquine Sulfate	102	$5,797	$57
Methotrexate	96	$5,462	$57
Prednisone	143	$4,028	$28
Diclofenac	28	$1,922	$69
Allopurinol	31	$1,261	$41
Alendronate	28	$346	$12

2017: 10 drugs

Sort by

Part D drugs prescribed in 2017

Rayos	14	$137,158	$9,797
Colchicine	25	$8,063	$323
Prednisone	120	$3,463	$29
Methotrexate	63	$3,329	$53
Hydroxychloroquine Sulfate	38	$3,202	$84
Diclofenac	24	$1,821	$76
Allopurinol	24	$970	$40
Sulfasalazine	12	$919	$77
Alendronate	14	$199	$14
Lidocaine	11	$178	$16

2016: 10 drugs

Sort by

Part D drugs prescribed in 2016

Enbrel	18	$68,912	$3,828
Colchicine	27	$6,506	$241
Hydroxychloroquine Sulfate	24	$4,721	$197
Methotrexate	26	$1,912	$74
Prednisone	32	$764	$24
Allopurinol	16	$495	$31
Hydrocodone-Acetaminophen	14	$438	$31
Sulfasalazine	11	$392	$36
Omeprazole	16	$160	$10
Ibuprofen	12	$94	$8

2015: 2 drugs

Sort by

Part D drugs prescribed in 2015

Methotrexate	14	$944	$67
Prednisone	12	$164	$14

Money from drug and device companies

$247 in 2023

Sort by

Industry payments by year

2023	1	3	None	$247
2022	2	2	None	$149
2020	1	3	None	$167
2019	1	1	None	$37

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Abbvie	Rinvoq	$247	3 payments Meals for Skyrizi · 2023-11-15 · $101 Meals for Skyrizi · 2023-11-13 · $21 Meals for Rinvoq · 2023-09-28 · $125

See all 3 published payments

Sort by

Every published payment

Abbvie	Meals · 2023-11-15	Skyrizi	$101
Abbvie	Meals · 2023-11-13	Skyrizi	$21
Abbvie	Meals · 2023-09-28	Rinvoq	$125

See earlier years (2022, 2020, 2019)

2022: $149

Sort by

Payments by company in 2022

Abbvie	Rinvoq	$103	1 payment Meals for Rinvoq · 2022-07-27 · $103
Aurinia Pharma U.S.	Lupkynis	$45	1 payment Meals for Lupkynis · 2022-06-06 · $45

2020: $167

Sort by

Payments by company in 2020

Amgen	Evenity	$167	3 payments Meals for Evenity · 2020-02-12 · $34 Meals for Evenity · 2020-01-27 · $53 Meals for Enbrel · 2020-01-07 · $81

2019: $37

Sort by

Payments by company in 2019

Amgen	Enbrel	$37	1 payment Meals for Enbrel · 2019-08-21 · $37

Professional record

NPI: 1043523327
Licence: CA A118120California A118120: Current · expires 2027-08-31
Trained: University of California, Irvine, California College of Medicine, 2010
Group: Permanente Medical Group Inc
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RR0500X (207RR0500X); Student in a training program (390200000X)
Mailing address: 300 Pasteur Dr, Stanford Medicine Residency Office, Grant S101, Stanford, CA, 94305
NPI first listed: 2010-07-15
NPI last updated: 2022-01-10

This is when the NPI record was last certified, not a medical board exam.

This office lists an electronic records connection.